Terms: = Testicular cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
384 results:
1. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
2. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract] [Full Text] [Related]
3. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
[TBL] [Abstract] [Full Text] [Related]
4. SMARCB1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiology, Management, and Survival Outcomes of Germ Cell cancer in Southern Portugal: A Population-Based Study (2008-2012).
Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
[TBL] [Abstract] [Full Text] [Related]
6. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract] [Full Text] [Related]
7. Origin and outcome of metastatic tumours to the testes: a nationwide study.
Woortman C; van Leenders GJLH; Hugen N; van Oijen MGH; Nagtegaal ID
BJU Int; 2024 Mar; 133(3):305-313. PubMed ID: 37877215
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Lauritsen J; Sauvé N; Tryakin A; Jiang DM; Huddart R; Heng DYC; Terbuch A; Winquist E; Chovanec M; Hentrich M; Fankhauser CD; Shamash J; Del Muro XG; Vaughn D; Heidenreich A; Sternberg CN; Sweeney C; Necchi A; Bokemeyer C; Bandak M; Jandari A; Collette L; Gillessen S; Beyer J; Daugaard G
Br J Cancer; 2023 Nov; 129(11):1759-1765. PubMed ID: 37777577
[TBL] [Abstract] [Full Text] [Related]
9. Conditional survival of stage III non-seminoma testis cancer patients.
Incesu RB; Barletta F; Tappero S; Morra S; Garcia CC; Scheipner L; Piccinelli ML; Tian Z; Saad F; Shariat SF; de Cobelli O; Ahyai S; Chun FKH; Longo N; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Urol Oncol; 2023 Oct; 41(10):435.e11-435.e18. PubMed ID: 37558516
[TBL] [Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of malignant mesothelioma of the tunica vaginalis testis: a series of 7 cases].
Huang KB; Cao Y; Yao K; Zhou FJ; Liu ZW; Li XD
Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):812-817. PubMed ID: 37491176
[No Abstract] [Full Text] [Related]
11. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
12. Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience.
Novotný R; Donátová Z; Büchler T; Kristek J; Froněk J; Janousek L
Rozhl Chir; 2023; 102(4):154-158. PubMed ID: 37344195
[TBL] [Abstract] [Full Text] [Related]
13. Patterns of Relapse in Australian Patients With Clinical Stage 1 testicular cancer: Utility of the Australian and New Zealand Urogenital and Prostate cancer Trials Group Surveillance Recommendations.
Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
[TBL] [Abstract] [Full Text] [Related]
14. Primary Mediastinal Germ Cell Tumors (PMGCT): A Real-world Analysis From A Tertiary cancer Care Center in India.
Sharma A; Reddy R; Pramanik R; Sahoo RK; Kaushal S; Haresh KP; Kumar S; Kumar L; Sharma A; Batra A
Cancer Invest; 2023 May; 41(5):467-473. PubMed ID: 36927242
[TBL] [Abstract] [Full Text] [Related]
15. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Antonelli L; Ardizzone D; Ravi P; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Fizazi K; King JM; Adra N; Douglawi A; Cary C; Sweeney C; Fankhauser CD
Eur J Cancer; 2023 Mar; 182():144-154. PubMed ID: 36787661
[TBL] [Abstract] [Full Text] [Related]
16. Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features.
Del Fiore P; Cavallin F; Mazza M; Benna C; Monico AD; Tadiotto G; Russo I; Ferrazzi B; Tropea S; Buja A; Cozzolino C; Cappellesso R; Nicolè L; Piccin L; Pigozzo J; Chiarion-Sileni V; Vecchiato A; Menin C; Bassetto F; Dei Tos AP; Alaibac M; Mocellin S
Environ Health; 2022 Dec; 21(1):126. PubMed ID: 36482443
[TBL] [Abstract] [Full Text] [Related]
17. Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: A Surveillance, Epidemiology, and End Results-based Study.
Aguiar Bujanda D; Pérez Cabrera D; Croissier Sánchez L
Am J Clin Oncol; 2022 Dec; 45(12):493-500. PubMed ID: 36394133
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies.
Giampietri C; Scatozza F; Crecca E; Vigiano Benedetti V; Natali PG; Facchiano A
J Transl Med; 2022 Oct; 20(1):467. PubMed ID: 36224560
[TBL] [Abstract] [Full Text] [Related]
19. TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Bacon JVW; Giannatempo P; Cataldo G; Fazli L; Saxena N; Ozgun G; Soleimani M; Chi K; Nichols C; Necchi A; Wyatt AW; Kollmannsberger CK; Nappi L
Oncologist; 2022 Nov; 27(11):e912-e915. PubMed ID: 36166584
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/
Schultz KAP; Harris AK; Nelson AT; Watson D; Lucas JT; Miniati D; Stewart DR; Hagedorn KN; Mize W; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Harney LA; Rodriguez Galindo C; Bisogno G; Dehner LP; Hill DA; Messinger YH
J Clin Oncol; 2023 Feb; 41(4):778-789. PubMed ID: 36137255
[TBL] [Abstract] [Full Text] [Related]
[Next]
